Spasticity
📧 Sign up to get email alerts when something new happens for Spasticity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: Ultrasonograpy in Hemiplegic Patients
Active, not-recruiting clinical trial at Afyonkarahisar Health Sciences University evaluating ultrasonography in hemiplegic patients, includ…
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Long-term Efficacy of Spasticity-correcting Surgery and Botulinum Toxin Injections for Upper Limb Spasticity Treatment [NA]
A completed clinical trial update assessing long-term effectiveness of spasticity treatments in the upper limb, combining spasticity-correct…
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: Effects of Baclofen on Presynaptic Inhibition in Humans [Phase 2]
A Phase 2 trial evaluating baclofen's effects on presynaptic inhibition in humans has been withdrawn.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Extracorporeal Shock Wave Therapy on Spastic Equinus Foot in Stroke Patients [NA]
A clinical trial is currently recruiting to evaluate the effectiveness of extracorporeal shock wave therapy for spastic equinus foot in stro…
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: Medtronic PSR TDD PMCF
Clinical trial update indicates the Medtronic PSR TDD PMCF study has completed, evaluating its use for chronic pain and spasticity.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Untreated Sleep Apnea as an Aggravating Factor for Other Secondary Medical Conditions After Spinal Cord Injury
A completed clinical trial examined whether untreated sleep apnea worsens secondary medical conditions after spinal cord injury, including s…
-
CLINICAL_TRIALS withdrawal · 2023-11-22Clinical Trial Update: The Effect of Ultrasound-Guided Botulinum Toxin Injections on Pain, Functionality, Spasticity, and Range of Motion in Patients With Post-Stroke Upper Extremity Spasticity [Phase 4]
A Phase 4 clinical trial evaluating ultrasound-guided botulinum toxin injections for post-stroke upper extremity spasticity has been withdra…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Efficacy of Extracorporeal Shock Wave Therapy in Children With Cerebral Palsy [Phase 3]
A Phase 3 clinical trial evaluating the efficacy of extracorporeal shock wave therapy for spasticity in children with cerebral palsy.
-
FDA approval · 2023-10-11FDA Approved: VALIUM — Supplemental Application (Roche Laboratories Inc.)
FDA approved a Supplemental Application for Valium (diazepam) from Roche Laboratories Inc., indicating an approved change or addition to the…
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Phase II Study to Assess Safety, Pharmacokinetics and Efficacy of SL-1002 for Limb Spasticity [Phase 2]
Phase II study assessing safety, pharmacokinetics, and efficacy of SL-1002 for limb spasticity is in progress.
-
CLINICAL_TRIALS trial_result · 2023-03-07Clinical Trial Update: Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb Spasticity [Phase 2, Phase 3]
Clinical trial update on MYOBLOC for adult lower limb spasticity, spanning Phase 2 and Phase 3 to evaluate efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2023-03-07Clinical Trial Update: Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity [Phase 2, Phase 3]
Clinical trial update for MYOBLOC in adult upper limb spasticity across Phase 2 and Phase 3, focusing on efficacy and safety.
-
FDA approval · 2023-02-22FDA Approved: BACLOFEN — Original Application (Nexus Pharmaceuticals LLC)
FDA approves Nexus Pharmaceuticals LLC's original ANDA for baclofen, a generic treatment for spasticity conditions.
-
FDA approval · 2023-02-08FDA Approved: DIAZEPAM — Supplemental Application (Natco Pharma USA LLC)
FDA approved Natco Pharma USA LLC's supplemental application for Diazepam (generic) under ANDA210363. This approval advances the generic Dia…
-
CLINICAL_TRIALS trial_result · 2022-07-15Clinical Trial Update: A Study to Evaluate the Long-term Safety of Arbaclofen Extended-Release Tablets for Patients With Spasticity Due to MS [Phase 3]
Phase 3 trial assessing long-term safety of arbaclofen extended-release tablets for spasticity due to multiple sclerosis; study completed wi…
-
FDA approval · 2022-05-31FDA Approved: GABLOFEN — Supplemental Application (Piramal Critical Care Inc)
FDA approved a supplemental application for GABLOFEN (baclofen injection) from Piramal Critical Care Inc.
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis [Phase 3]
Phase 3 trial update evaluating arbaclofen for spasticity in multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With Spasticity [Phase 3]
Phase 3 open-label dose-escalation long-term safety study in multiple sclerosis patients with spasticity completed.
-
CLINICAL_TRIALS trial_result · 2021-11-26Clinical Trial Update: Compare Two Guidance Techniques for Botulinum Toxin Injections for the Treatment of Limb Spasticity and Focal Dystonia [NA]
A completed clinical trial comparing guidance techniques for botulinum toxin injections in limb spasticity and focal dystonia; results poste…
-
FDA approval · 2021-11-22FDA Approved: LYVISPAH — Original Application (Amneal Pharmaceuticals LLC)
FDA approved LYVISPAH (baclofen) from Amneal Pharmaceuticals LLC as an Original Application. It is indicated for the management of spasticit…
-
FDA approval · 2021-09-22FDA Approved: BACLOFEN — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for baclofen from Chartwell RX, LLC, under ANDA077241, indicating regulatory approval of this supple…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity [Phase 4]
Phase 4 trial comparing three Botox-A preparations for spasticity in stroke and brain injury patients; results posted after completion.
-
FDA approval · 2021-01-15FDA Approved: BACLOFEN — Original Application (MAlA Pharmaceuticals, Inc.)
FDA approved the original application for baclofen, authorizing its marketing as a generic drug from MAlA Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2020-11-05Clinical Trial Update: Imaging of 3D Innervation Zone Distribution in Spastic Muscles From High-density Surface EMG Recordings [Phase 4]
Phase 4 clinical trial update examining imaging of 3D innervation zone distribution in spastic muscles using high-density surface EMG record…
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy [Phase 3]
Phase 3 trial evaluating dose-response efficacy and safety of Botulinum Toxin Type A for spasticity in limbs related to cerebral palsy; stud…